Table 1. CLLs used for in vitro assays... | Rockefeller University Press

Table 1.

CLLs used for in vitro assays

CLL ID#	AID expression	WBCs	% lymph	Sex	Age at diagnosis	Treatment
					yr
JE1015^a	−	20.4	58.1	M	86	none
JE1019^a^b^c	−	102.5	95.8	M	76	none
JE1031^a	−	32.6	80.7	F	47	none
JE1056^b^c	−	68.1	91.1	M	70	none
JE1057^a	−	31.3	81.3	F	64	none
JE1069^b^c	−	44.1	91.7	F	74	none
JE1088^b^c	−	135.4	93.5	M	67	none
JE1095^b^c	−	80.7	90.0	M	81	none
JE1010^a	+	43.6	83.2	F	51	none
JE1036^a	+	22.6	65	M	63	none
JE1044^b^c	+	55.3	93.7	F	57	i.v. Ig
JE1045^b^c	+	17.1	68.7	M	62	fludarabine
JE1046^b^c	+	47.8	89.5	M	79	none
JE1070^a^b^c	+	78.3	91.0	M	53	chlorambucil
JE1075^a	+	39.3	87.6	F	72	none
JE1098^b^c	+	41.2	86.0	F	73	chlorambucil

CLL ID#	AID expression	WBCs	% lymph	Sex	Age at diagnosis	Treatment
					yr
JE1015^a	−	20.4	58.1	M	86	none
JE1019^a^b^c	−	102.5	95.8	M	76	none
JE1031^a	−	32.6	80.7	F	47	none
JE1056^b^c	−	68.1	91.1	M	70	none
JE1057^a	−	31.3	81.3	F	64	none
JE1069^b^c	−	44.1	91.7	F	74	none
JE1088^b^c	−	135.4	93.5	M	67	none
JE1095^b^c	−	80.7	90.0	M	81	none
JE1010^a	+	43.6	83.2	F	51	none
JE1036^a	+	22.6	65	M	63	none
JE1044^b^c	+	55.3	93.7	F	57	i.v. Ig
JE1045^b^c	+	17.1	68.7	M	62	fludarabine
JE1046^b^c	+	47.8	89.5	M	79	none
JE1070^a^b^c	+	78.3	91.0	M	53	chlorambucil
JE1075^a	+	39.3	87.6	F	72	none
JE1098^b^c	+	41.2	86.0	F	73	chlorambucil

Used in in vitro viability assays (Fig. 4 A).

Used in γ-H2AX immunofluorescence assays (Fig. 7, A–C; and Fig. 8).

Used in AC3 immunofluorescence assays (Fig. 4, B and C).